COMMUNIQUÉS West-GlobeNewswire

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
12/03/2024
COPENHAGEN, Denmark, March 12, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial [...]
ARC Resources Ltd. donates $5 million to OWN.CANCER Campaign ahead of opening of new Arthur J.E. Child Comprehensive Cancer Centre in Calgary
12/03/2024
This is the campaign’s largest corporate gift and will support clinical trials and innovations in radiation oncology CALGARY, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- The Alberta Cancer Foundation, along with Alberta [...]
Fortrea signe un accord définitif pour céder les activités Endpoint Clinical et Patient Access à Arsenal Capital Partners
12/03/2024
Le projet de cession des activités Endpoint Clinical et Fortrea Patient Access permet à Fortrea de se recentrer sur son cœur de métier stratégique d’organisme de recherche contractuelle Création de solutions autonomes [...]
SaharaBets Partners with Birches Health to Increase Accessibility to Responsible Gaming Resources and Problem Gambling Treatment
12/03/2024
PHOENIX, Arizona, March 12, 2024 (GLOBE NEWSWIRE) -- SaharaBets and Birches Health announced the formation of a partnership focusing on proactive engagement and education in Responsible Gaming. The partnership provides [...]
Ibogaine By David Dardashti Announces New Algorithm to Address PTSD
12/03/2024
Groundbreaking Algorithm to Help Treat Trauma Victims MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti , a company that specializes in helping people heal from trauma, has announced a revolutionary [...]
Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
12/03/2024
Green Light for Phase 2 Trial of AST-004 in Acute Ischemic Stroke Patients GROTON, Conn., March 12, 2024 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc. , a clinical-stage biopharmaceutical company committed to [...]
Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference
12/03/2024
EAGLE, Idaho, March 12, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
12/03/2024
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group ") (CSE: PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and [...]
Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya
12/03/2024
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food [...]
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
12/03/2024
GRANTS, NEW MEXICO, March 12, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) today announced that it has signed an agreement with Dalsem Greenhouse Technologies BV for [...]
Middlesex Recovery Earns Three-Year CARF Accreditation
12/03/2024
LEWISVILLE, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Middlesex Recovery is proud to announce that it has earned a Three-Year Accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF) for [...]
EverythingALS Launches the Vision 2030 AI Hub: Charting the Path to an ALS Cure and Advancing Neurodegenerative Disease Research
12/03/2024
Vision 2030 will utilize advanced technologies and an innovative operating model for research and drug development SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- EverythingALS, a leading force in the fight against [...]
Health-ISAC Supports Health Industry Cybersecurity Strategic Plan
12/03/2024
Joint effort gives measurable objectives toward resilience within 5 years ORMOND BEACH, Fla., March 12, 2024 (GLOBE NEWSWIRE) -- Health-ISAC, a non-profit, member driven organization is pleased to contribute to the [...]
Love for Liam Foundation to Host the Third Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 10, 2024
12/03/2024
PHILADELPHIA, March 12, 2024 (GLOBE NEWSWIRE) -- The Love for Liam Foundation , a 501(c)(3) nonprofit that seeks to raise awareness for pediatric epilepsy and drive research funding, today announced its Third Annual [...]
Healthcare Triangle, Inc. Appoints Anand Kumar as Interim CEO
12/03/2024
PLEASANTON, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a frontrunner in healthcare technology has announced the appointment of [...]
Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 Million
12/03/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a [...]
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY
12/03/2024
Rutherford, NJ, March 12, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel [...]
Celularity CEO to Present Keynote Address at 2024 Society for Brain Mapping and Therapeutics Annual World Congress
12/03/2024
Keynote Will Discuss Cellular Immunotherapy’s Potential for Treating Chronic Conditions, Including Cancer, Multiple Sclerosis and Parkinson’s Disease FLORHAM PARK, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Celularity Inc [...]
Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
12/03/2024
ART26.12 Preclinical Dermatology Research Presented to the Immuno-dermatology Leadership Team at Johnson & Johnson SOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a [...]

Pages